(Washington), 12-15 year-old children of Pfizer, more than four months after the second injection vaccine kovid -19 “100%” to be effective, the company said on Monday, that the application for relief, supporting the full power of the updated data. This age group.
Pfizer-bayoentek alliance vyaksinku from the United States in May and is currently in an emergency use authorization has been granted for teens.
The companies on Monday released updated information from their clinical trial of more than 2,200 adolescents between the ages of 12 and 15.
Participants were followed for at least four months after the second injection: 30 COVID-19 cases were recorded in the placenta receiving adolescence compared with any cases in the vaccinated group. 100% effect against pathological cases of the disease.
The data were collected between November 2020 and September 2021, Pfizer said in his press statement.
In addition, the pharmaceutical giant added that “no serious safety issues were observed in individuals with at least six months of follow-up.”
Messenger RNA vaccines from Pfizer and Modernna increase the risk of myocarditis and myocardial infarction, especially in adolescent males. But these cases are very rare and in the opinion of experts, the benefits of the vaccine continue to outweigh this risk.
“These additional data on the efficacy and safety profile of adolescents in our vaccine provides additional confidence that” Albert Bauer, CEO of Pfizer, said in a statement.
“The United States and around the world,” the power to request the results give evidence for the vaccine, according to the company, it does not give a timeline.
The Pfizer vaccine was fully authorized in the United States in August for people 16 years of age and older.